Attached files
file | filename |
---|---|
EX-10.10 - EX-10.10 - VERTEX PHARMACEUTICALS INC / MA | a10k_2020-exhibit1010.htm |
10-K - 10-K - VERTEX PHARMACEUTICALS INC / MA | vrtx-20201231.htm |
EX-10.6 - EX-10.6 - VERTEX PHARMACEUTICALS INC / MA | a10k_2020-exhibit106.htm |
EX-32.1 - EX-32.1 - VERTEX PHARMACEUTICALS INC / MA | a10k_2020-exhibit321.htm |
EX-21.1 - EX-21.1 - VERTEX PHARMACEUTICALS INC / MA | a10k_2020-exhibit211.htm |
EX-31.1 - EX-31.1 - VERTEX PHARMACEUTICALS INC / MA | a10k_2020-exhibit311.htm |
EX-31.2 - EX-31.2 - VERTEX PHARMACEUTICALS INC / MA | a10k_2020-exhibit312.htm |
EX-23.1 - EX-23.1 - VERTEX PHARMACEUTICALS INC / MA | a10k_2020-exhibit231.htm |
Exhibit 10.41
Vertex Pharmaceuticals Incorporated Annual Non-Employee Board Compensation | ||||||||
Annual Retainer | $100,000 | |||||||
Committee Chair Compensation | ||||||||
Audit & Finance Committee Chair | $30,000 annual retainer | |||||||
Management Development & Compensation Committee Chair | $25,000 annual retainer | |||||||
Corporate Governance & Nominating Committee Chair | $20,000 annual retainer | |||||||
Science & Technology Committee Chair | $20,000 annual retainer | |||||||
Committee Membership Fee (Non-Chairs) | ||||||||
Audit & Finance Committee Member | $15,000 annual retainer | |||||||
Management Development & Compensation Committee Member | $12,500 annual retainer | |||||||
Corporate Governance & Nominating Committee Member | $10,000 annual retainer | |||||||
Science & Technology Committee Member | $10,000 annual retainer | |||||||
Lead Independent Director Compensation | $40,000 annual retainer | |||||||
Annual Equity Grants | ||||||||
Annually on May 1, $400,000 in value-based awards, comprised at the director's election of restricted stock units and/or options •Options are fully vested upon grant •Restricted stock units cliff vest on the 1 year anniversary of the grant date | ||||||||
Initial Equity Grants | ||||||||
On date director joins the board of directors, a $400,000 restricted stock unit award that vests on the first anniversary of the grant date. | ||||||||
Each of our non-employee directors is eligible to defer the cash and restricted stock portion of his/her compensation set forth above and elect to receive deferred stock units that convert to common stock in specified circumstances. |